LUP Statistics
Record
- Title
- Lenalidomide-bendamustine-rituximab in untreated mantle cell lymphoma > 65 years, the Nordic Lymphoma Group phase I+II trial NLG-MCL4
- Type
- Journal Article
- Publ. year
- 2016
- Author/s
- Albertsson-Lindblad, Alexandra; Kolstad, Arne; Laurell, Anna; Räty, Riikka et al.
- Department/s
- Lymphoma - Clinical Research; Tumor microenvironment; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
- In LUP since
- 2016-10-13
Downloads
Total | This Year | This Month |
275 | 24 | 2 |
United States of America | 153 (56%) |
China | 34 (13%) |
Germany | 15 (6%) |
Sweden | 12 (4%) |
Russian Federation | 6 (2%) |
France | 5 (2%) |
Ireland | 4 (1%) |
Japan | 4 (1%) |
Viet Nam | 4 (1%) |
Denmark | 3 (1%) |
Hong Kong (China) | 3 (1%) |
Unknown | 2 (1%) |
Greece | 2 (1%) |
Ukraine | 2 (1%) |
Brazil | 2 (1%) |
Canada | 2 (1%) |
South Korea | 2 (1%) |
Australia | 2 (1%) |
Mexico | 2 (1%) |
Nigeria | 2 (1%) |
India | 1 (0%) |
Switzerland | 1 (0%) |
Spain | 1 (0%) |
Colombia | 1 (0%) |
Poland | 1 (0%) |
Norway | 1 (0%) |
Taiwan (China) | 1 (0%) |
Saudi Arabia | 1 (0%) |
United Kingdom of Great Britain and Northern Ireland | 1 (0%) |
Netherlands (Kingdom of the) | 1 (0%) |